Q8Y6X4 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihydt6ax5ukiyjfnkp6ygvz4bki2ikpzik3qomtlc2qstwoefxfu4/metadata.json
IPFS of structure file: 
bafybeidkwwrtxirw3ekallqzrnabpkk4supkxzbrjleq26wj5hehtmwm5e/AF-Q8Y6X4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x914Cf855d9d82C2372728B1b657855010b64Bbfe
First NFT owner address (bech32): 
genesis1j9x0s4wemqkzxunj3vdk27z4qy9kfwl7wmyvez
Current NFT ID #166690 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
166690
Accession (UniProt):
Q8Y6X4
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
LISTERIA MONOCYTOGENES SEROVAR 1/2A (STRAIN ATCC BAA-679 / EGD-E)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8Y6X4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8Y6X4|HEM1_LISMO Glutamyl-tRNA reductase OS=Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) OX=169963 GN=hemA PE=3 SV=1 MFILTMGLNHHTAPIDIREKLVFKETEEEMALVTLQQEKSILENVIISTCNRTEIVAVVDQIHTGRYYLKRFMANWFQMDMEKIEPYLFFHEETEAVNHLYKVTAGLDSLVLGETQILGQVKHAFEIAKQTETTGTLLNKLFREVVTFAKKVHHHTKINENAVSVSYAAVEVAKKLYGSLDNKKIVLVGAGEMSELALQNLAGSGIADITIINRTKSNAELLANQFQAKVGAYENMNEHLMLADIVLVSTSATEPIIKQAAMQDLMEQKASSMLVIDIGLPRNVEHDCSYIPNFHLYDIDDLAGVVSANSLERQRIVLELENTIEVEVRNFFEWEKQLGVVPVIRALREKALDMQEVAMTSLENKLPGLTEREYIQIGKHMKSIINQMLKQPISELKEMSVEEDATTSIEHFKRIFGLSETDVTVIEKEQAETRS